Substance ≠ exposure
The prescribed dose is not itself the concentration and duration encountered by the body.
BODY · RESEARCH AUDIT v0.1
The same tablet is not necessarily the same treatment.
Medicine examined through the relation between substance, female physiology, internal exposure, hormones, life stage, history, time and the capacity to recover.
Boundary: This is a research audit, not individual treatment, dosage or discontinuation guidance. Do not change medication without consulting the relevant healthcare professional.
Two people receive the same diagnosis, medicine and dose.
≠Have they therefore received the same biological exposure and the same access to recoverability?
CHOOSE A TRACE
Ten audits, distributed across five entrances
Each group opens on its own lightweight page. Documentation loads only when you choose it.
01 · 3 AUDITS
Psychiatry, sleep and attention
SSRIs, Z-drugs and ADHD medicine.
EXPLORE →02 · 2 AUDITSPain and inflammation
NSAIDs and opioids.
EXPLORE →03 · 2 AUDITSHeart and circulation
Statins and blood-pressure medicine.
EXPLORE →04 · 2 AUDITSMetabolism and thyroid
Metformin, semaglutide and thyroid hormone.
EXPLORE →05 · 1 AUDITStomach and digestion
PPIs: omeprazole and pantoprazole.
EXPLORE →ACROSS GROUPSWhat repeats?
Standard dose, proxy outcomes, discontinuation, false anchors and missing life-stage data.
SEE CROSS-CUTTING FINDINGS →METHOD SPINE
Differences must not collapse into one outcome
Proxy ≠ function
A biomarker may change without describing daily function or total burden.
Transition ≠ stable state
Symptoms during change must not automatically be read as the new lasting state.
Absence ≠ equality
Missing data or significance does not demonstrate that bodies respond equally.